SOUTH SAN FRANCISCO, Calif., June 27, 2025 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX) today announced that following the review of data from the recently terminated BEACON-IPF ...

A study may have found a cure for type 1 diabetes. Here, experts explain how the treatment, zimislecel, works and what it means for diabetes.

How Australian pregnant women are tested for gestational diabetes is set to change, with new national guidelines released today. Changes are expected to lead to fewer diagnoses in women at lower ...

Learn about early diabetes symptoms, diabetic diet information, diabetes care, type 1 diabetes, insulin resistance and type 2 diabetes. Read the latest medical research on diabetes.

Explore Pliant Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for PLRX.

A study may have found a cure for type 1 diabetes. Here, experts explain how the treatment, zimislecel, works and what it means for diabetes.

Pliant Therapeutics has discontinued the bexotegrast development for idiopathic pulmonary fibrosis (IPF) following a review of data from the terminated global, double-blind, randomised, placebo ...

Among the four diet types trialed in this study, a modified version of the DASH diet with reduced sodium intake achieved a better overall decrease in blood pressure in people with type 2 diabetes.

The cure for diabetes is a life free from daily insulin injections. Based on that criterion, ten out of 12 people (83%) in a new clinical trial were cured of their diabetes one year after ...

People with both diabetes and asthma appear to face greater metabolic risks than those with either condition alone, according to new observational data.

Semaglutide — the active ingredient in type 2 diabetes and weight-loss glucagon-like peptide-1 agonist ( GLP-1) medications Ozempic and Wegovy — may help lower dementia risk, a new study finds.